A groundbreaking study conducted by the UK Dementia Research Institute team at Cardiff University suggests that smartwatches may have the potential to diagnose Parkinson’s disease up to seven years before the onset of symptoms. By utilizing artificial intelligence and analyzing data from over 100,000 smartwatch wearers, researchers were able to predict individuals who would develop Parkinson’s based on their speed of movement tracked over a single week between 2013 and 2016. The findings raise the possibility of using smartwatches as a screening tool for early detection.
Parkinson’s disease is a neurodegenerative disorder characterized by the gradual deterioration of brain cells over time. Common symptoms include involuntary shaking or tremors, slow movement, and stiff and inflexible muscles. Unfortunately, by the time a diagnosis is made, irreversible damage to brain cells has often occurred. The potential of smartwatches to identify early-stage Parkinson’s could be significant, particularly since approximately 30% of the UK population wears these devices, according to study leader Dr. Cynthia Sandor.
The research team’s analysis of data from the UK Biobank, a comprehensive health database comprising over half a million individuals, demonstrated promising results. Comparing the model with other movement-affecting conditions such as old age or frailty, the researchers found that it accurately distinguished Parkinson’s disease. Dr. Kathryn Peall, a researcher involved in the study, emphasized that this work could help identify Parkinson’s in its early stages and differentiate it from other disorders affecting movement.
While the potential for early detection offers numerous advantages, the question of whether individuals should be informed of a Parkinson’s diagnosis years before symptoms appear remains a personal choice. However, Dr. Peall noted that this research holds promise for the field by paving the way for the development of therapies that could slow disease progression. Access to early treatments could become a reality in the future, benefiting both research and clinical practice.
Further studies are necessary to validate and compare these findings with data collected worldwide to ensure their accuracy and reliability. The researchers acknowledge the need for additional research to fully establish smartwatches as a screening tool for Parkinson’s disease.
The ability to diagnose Parkinson’s disease well in advance of symptoms would mark a significant advancement in medical science, offering new opportunities for early intervention and improved patient outcomes. Continued research and advancements in the field hold the potential to transform the approach to Parkinson’s disease, ultimately leading to earlier access to treatments and the ability to slow disease progression.
More news from Cardiff
